Session highlights from the American College of Cardiology Scientific Sessions: March 29 to April 1, 1998.
Alexander
J H
JH
Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Greenbaum
A B
AB
Hudson
M P
MP
Kong
D F
DF
Miller
J M
JM
Tung
C Y
CY
Whellan
D J
DJ
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001067:Appetite Depressants / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000517:prevention & control*; D004594:Electrophysiology / Q000379:methods*; D005260:Female; D005277:Fenfluramine / Q000009:adverse effects; D006330:Heart Defects, Congenital / Q000139:chemically induced*; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017180:Tachycardia, Ventricular / Q000188:drug therapy / Q000503:physiopathology; D014481:United States
D000889:Anti-Arrhythmia Agents; D000924:Anticholesteremic Agents; D001067:Appetite Depressants; D005277:Fenfluramine